Panion & Bf Biotech Inc. (TPE:1760)
Taiwan · Delayed Price · Currency is TWD 62.20
-1.70 (-2.66%)
At close: Jul 9, 2026
Panion & Bf Biotech Market Cap
Panion & Bf Biotech has a market cap or net worth of 5.33 billion as of July 9, 2026. Its market cap has decreased by -17.07% in one year.
Market Cap
5.33B
Enterprise Value
5.53B
Revenue
2.10B
Ranking
n/a
PE Ratio
25.08
Stock Price
62.20
Market Cap Chart
Since September 30, 2004, Panion & Bf Biotech's market cap has increased from 534.45M to 5.33B, an increase of 897.83%. That is a compound annual growth rate of 11.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 5.33B | -1.27% |
| Dec 31, 2025 | 5.40B | -23.26% |
| Dec 31, 2024 | 7.04B | -26.70% |
| Dec 29, 2023 | 9.60B | -37.43% |
| Dec 30, 2022 | 15.35B | 138.03% |
| Dec 30, 2021 | 6.45B | -1.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Standard Chemical & Pharmaceutical | 11.37B |
| Alar Pharmaceuticals | 8.62B |
| Formosa Laboratories | 6.75B |
| Orient Pharma | 6.07B |
| SCI Pharmtech | 5.35B |
| LIWANLI Innovation | 4.92B |
| Easywell Biomedicals | 4.19B |
| Orient EuroPharma | 4.18B |